These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28491340)

  • 1. The Financial Impact of Advanced Kidney Disease on Canada Pension Plan and Private Disability Insurance Costs.
    Manns B; McKenzie SQ; Au F; Gignac PM; Geller LI;
    Can J Kidney Health Dis; 2017; 4():2054358117703986. PubMed ID: 28491340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating a Change from TRICARE to Commercial Insurance Plans.
    Murray CT; Schmit M
    Mil Med; 2018 Nov; 183(11-12):e354-e358. PubMed ID: 29547994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What can the Canadians and Americans learn from each other's health care systems?
    Weil TP
    Int J Health Plann Manage; 2016 Jul; 31(3):349-70. PubMed ID: 27469581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disability benefit coverage and program interactions in the working-age population.
    Rupp K; Davies PS; Strand A
    Soc Secur Bull; 2008; 68(1):1-30. PubMed ID: 18837269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TANF/SSI connection.
    Wamhoff S; Wiseman M
    Soc Secur Bull; 2005-2006; 66(4):21-36. PubMed ID: 17590982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cost of Care for People With Chronic Kidney Disease.
    Manns B; Hemmelgarn B; Tonelli M; Au F; So H; Weaver R; Quinn AE; Klarenbach S;
    Can J Kidney Health Dis; 2019; 6():2054358119835521. PubMed ID: 31057803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health USA. A national health program for the United States.
    Brown ER
    JAMA; 1992 Jan 22-29; 267(4):552-8. PubMed ID: 1729579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Questions and answers on employee benefit issues.
    EBRI Issue Brief; 1994 Jun; (150):1-33. PubMed ID: 10134782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF; Escarce JJ; Solomon MD; Goldman DP
    JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability in two health care systems: access, quality, satisfaction, and physician contacts among working-age Canadians and Americans with disabilities.
    Gulley SP; Altman BM
    Disabil Health J; 2008 Oct; 1(4):196-208. PubMed ID: 21122730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prevalence of CKD in Rural Canadian Indigenous Peoples: Results From the First Nations Community Based Screening to Improve Kidney Health and Prevent Dialysis (FINISHED) Screen, Triage, and Treat Program.
    Komenda P; Lavallee B; Ferguson TW; Tangri N; Chartrand C; McLeod L; Gordon A; Dart A; Rigatto C
    Am J Kidney Dis; 2016 Oct; 68(4):582-590. PubMed ID: 27257016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-control mechanisms in Canadian private drug plans.
    Kratzer J; McGrail K; Strumpf E; Law MR
    Healthc Policy; 2013 Aug; 9(1):35-43. PubMed ID: 23968672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Canada Pension Plan's experience with investing its portfolio in equities.
    Sarney M; Preneta AM
    Soc Secur Bull; 2001-2002; 64(2):46-56. PubMed ID: 12428509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Government and private insurance medical programs as well as MDVIP, an update.
    Edlich RF; Winters KL; Brit LD; Long WB
    J Long Term Eff Med Implants; 2004; 14(3):243-50. PubMed ID: 15301667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disability payments for persons with severe mental illness in Alberta, Canada.
    Block R; Slomp M; Patten S; Jacobs P; Ohinmaa AE; Dewa CS
    Psychiatr Serv; 2009 May; 60(5):686-8. PubMed ID: 19411359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical policies: effects of cap and co-payment on rational drug use.
    Austvoll-Dahlgren A; Aaserud M; Vist G; Ramsay C; Oxman AD; Sturm H; Kösters JP; Vernby A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD007017. PubMed ID: 18254125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Canadian initiatives to reimburse live organ donors for their non-medical expenses.
    Vlaicu S; Klarenbach S; Yang RC; Dempster T; Garg AX
    Can J Public Health; 2007; 98(6):481-3. PubMed ID: 19039887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Employer-paid nonmedical costs for patients with diabetes and end-stage renal disease.
    Kamal-Bahl SJ; Pantely S; Pyenson B; Alexander CM
    Prev Chronic Dis; 2006 Jul; 3(3):A83. PubMed ID: 16776884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France.
    Legrand K; Speyer E; Stengel B; Frimat L; Ngueyon Sime W; Massy ZA; Fouque D; Laville M; Combe C; Jacquelinet C; Durand AC; Edet S; Gentile S; Briançon S; Ayav C
    Am J Kidney Dis; 2020 Jun; 75(6):868-878. PubMed ID: 31879215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing replacement rates under private and federal retirement systems.
    Martin PP
    Soc Secur Bull; 2003-2004; 65(1):17-25. PubMed ID: 15218632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.